Stocks › AXSM
Axsome Therapeutics, Inc.
AXSM·Nasdaq·
United States·USD
United States·USD$174.34
-2.74 (-1.55%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
AXSM
Axsome Therapeutics, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AXSMS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of AXSM by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Christopher L. JacobsHouse · R · NY |
AXSMAxsome Therapeutics, Inc. · Stock |
Purchase $15,001 - $50,000 |
Jul 28, 2022 | Jun 16, 2022 | Filing ↗ |
Whale Activity
Position changes in AXSM reported for 2026-06-30 by 15 tracked institutional filers
- Increased6
- New0
- Held0
- Decreased4
- Closed0
- No prior filing5
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 3.1M | $759.7M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.0M | $485.5M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $481.0M | increased |
| TWO SIGMA INVESTMENTS, LP | 669.5K | $163.9M | increased |
| D. E. Shaw & Co., Inc. | 604.8K | $148.0M | increased |
| MILLENNIUM MANAGEMENT LLC | 556.1K | $136.1M | increased |
| Point72 Asset Management, L.P. | 416.5K | $102.0M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 262.0K | $64.1M | increased |
| CITADEL ADVISORS LLC | 255.9K | $62.6M | decreased |
| SAMLYN CAPITAL, LLC | 246.0K | $60.2M | — |
| Atika Capital Management LLC | 63.0K | $15.4M | — |
| Bridgewater Associates, LP | 58.2K | $14.2M | increased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by AXSM insiders, by quarter · Form 4
Recent Insider Transactions
180 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Jacobson Mark L.Chief Operating Officer | Sale | −10.0K | $208.65 | $2.1M | Sep 3, 2026 | Form 4 ↗ |
| TABUTEAU HERRIOTChief Executive Officer · Director | Sale | −4,660 | $213.95 | $997K | Aug 6, 2026 | Form 4 ↗ |
| TABUTEAU HERRIOTChief Executive Officer · Director | Sale | −45.0K | $212.01 | $9.5M | Aug 5, 2026 | Form 4 ↗ |
| TABUTEAU HERRIOTChief Executive Officer · Director | Sale | −49.7K | $240.25 | $11.9M | Jul 1, 2026 | Form 4 ↗ |
| JEFFS ROGERDirector | Sale | −286 | $249.12 | $71K | Jun 11, 2026 | Form 4 ↗ |
| JEFFS ROGERDirector | Sale | −286 | $246.18 | $70K | Jun 10, 2026 | Form 4 ↗ |
| Mahony SusanDirector | Sale | −300 | $246.18 | $74K | Jun 10, 2026 | Form 4 ↗ |
| Coleman MarkDirector | Sale | −643 | $249.00 | $160K | Jun 10, 2026 | Form 4 ↗ |
| Mahony SusanDirector | Sale | −300 | $237.21 | $71K | Jun 9, 2026 | Form 4 ↗ |
| TABUTEAU HERRIOTChief Executive Officer · Director · 10% owner | Sale | −49.7K | $241.01 | $12.0M | Jun 9, 2026 | Form 4 ↗ |
| TABUTEAU HERRIOTChief Executive Officer · Director · 10% owner | Option exercise | +49.7K | $4.95 | $246K | Jun 9, 2026 | Form 4 ↗ |
| Pizzie NickChief Financial Officer | Sale | −33.0K | $240.09 | $7.9M | Jun 9, 2026 | Form 4 ↗ |
| Pizzie NickChief Financial Officer | Option exercise | +33.0K | $3.50 | $116K | Jun 9, 2026 | Form 4 ↗ |
| JEFFS ROGERDirector | Option exercise | +1,429 | — | — | Jun 8, 2026 | Form 4 ↗ |
| Saad Mark EDirector | Option exercise | +1,429 | — | — | Jun 8, 2026 | Form 4 ↗ |
| Mahony SusanDirector | Option exercise | +1,429 | — | — | Jun 8, 2026 | Form 4 ↗ |
| Coleman MarkDirector | Option exercise | +1,429 | — | — | Jun 8, 2026 | Form 4 ↗ |
| Coleman MarkDirector | Sale | −5,537 | $223.39 | $1.2M | Jun 2, 2026 | Form 4 ↗ |
| Coleman MarkDirector | Sale | −6,000 | $230.30 | $1.4M | Jun 1, 2026 | Form 4 ↗ |
| Coleman MarkDirector | Sale | −6,000 | $233.46 | $1.4M | May 29, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding AXSM · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.4M | $339.9M | 0.01% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1.0M | $245.6M | 0.13% | Jun 30, 2026 |
| iShares Russell 2000 ETF iSHARES TRUST | 1.0M | $171.0M | 0.24% | Mar 31, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 578.2K | $141.5M | 0.30% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 495.8K | $121.3M | 0.12% | Jun 30, 2026 |
| VANGUARD EXPLORER FUND | 531.0K | $115.8M | 0.52% | Jul 31, 2026 |
| Invesco Discovery Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 468.5K | $109.9M | 1.40% | May 31, 2026 |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 426.1K | $104.3M | 3.71% | Jun 30, 2026 |
| Nomura Small Cap Core Fund Delaware Group Equity Funds V | 430.3K | $100.9M | 1.83% | May 29, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 409.7K | $85.1M | 0.26% | Apr 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list AXSM's shares (CUSIP 05464T104), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 2.7M shares5.3%
Jul 27, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Axsome Therapeutics, Inc. as client
No lobbying filings found naming Axsome Therapeutics, Inc. as the client.
Government Contracts
Federal awards to Axsome Therapeutics, Inc. · USAspending
No federal contract awards found for Axsome Therapeutics, Inc..
U.S. Patents
Recent USPTO applications naming Axsome Therapeutics, Inc.
No USPTO patent applications found for Axsome Therapeutics, Inc..
Annual Financials
From AXSM's 10-K filings · XBRL
No annual XBRL figures on record for AXSM. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in AXSM's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsAug 10, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJul 15, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeJun 9, 2026
EDGAR ↗ - 8-K · Items 5.07, 9.01Shareholder voteJun 9, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJun 3, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsMay 4, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsDec 31, 2025
EDGAR ↗
About Axsome Therapeutics, Inc.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersNEW YORK, NY
IncorporatedDE
SEC CIK0001579428 ↗